Evogene Ltd. - Ordinary Shares (EVGN)
EVGN moved a median of -0.48% 30 minutes after news, and -1.18% by the close. How EVGN actually reacts to news — the realized, point-in-time move the market made, measured across 213 labeled events over the last three years with zero look-ahead.
EVGN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 36% | 205 |
| 30-min | -0.48% | 38% | 211 |
| 60-min | -0.96% | 37% | 212 |
| to close | -1.18% | 39% | 206 |
| Middle 50% of EVGN reactions | -1.48% to +0.95% |
|---|---|
| Median reaction (30-min) | -0.48% |
| Measured reactions | 213 |
Half of all Evogene Ltd. - Ordinary Shares news events land between -1.48% and +0.95% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when EVGN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EVGN's baseline. Nothing else.
Recent EVGN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors | Press release | PR Newswire | -6.97% | -4.29% | |
| Form 6-K Evogene Ltd. For: Oct 06 | SEC filing · Form 6-K | SEC EDGAR | -6.97% | -4.29% | |
| Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance | Press release | PR Newswire | -1.51% | +1.82% | |
| Form 6-K Evogene Ltd. For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | -1.51% | +1.82% | |
| Form EFFECT Evogene Ltd. | SEC filing · Form EFFECT | SEC EDGAR | -1.51% | +1.82% | |
| Form 6-K Evogene Ltd. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +2.60% | +10.81% | |
| Form POS AM Evogene Ltd. | SEC filing · Form POS | SEC EDGAR | +2.60% | +10.81% | |
| Form 6-K Evogene Ltd. For: Sep 15 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -3.22% | |
| Form 6-K Evogene Ltd. For: Sep 04 | SEC filing · Form 6-K | SEC EDGAR | — | -2.20% | |
| Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward | Press release | PR Newswire | -2.74% | -1.85% | |
| Form 6-K Evogene Ltd. For: Aug 27 | SEC filing · Form 6-K | SEC EDGAR | -0.72% | -0.94% | |
| Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees | Press release | PR Newswire | +0.18% | -1.17% | |
| Evogene Reports Second Quarter and First Half 2026 Financial Results | Press release | PR Newswire | -0.66% | +4.04% | |
| Form 6-K Evogene Ltd. For: Aug 18 | SEC filing · Form 6-K | SEC EDGAR | -0.66% | +4.04% | |
| Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation | Press release | PR Newswire | -2.29% | -7.57% | |
| Form 6-K Evogene Ltd. For: Jul 31 | SEC filing · Form 6-K | SEC EDGAR | +0.41% | +9.84% | |
| Evogene Schedules Second Quarter 2026 Financial Results Release | Press release | PR Newswire | -1.96% | -4.04% | |
| Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases | Press release | PR Newswire | -1.91% | -1.02% | |
| Form 6-K Evogene Ltd. For: Jul 17 | SEC filing · Form 6-K | SEC EDGAR | -1.92% | -12.08% | |
| AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities | Press release | PR Newswire | -2.25% | +17.55% | |
| Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery | Press release | PR Newswire | +0.00% | -5.89% | |
| Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization | Press release | PR Newswire | -4.04% | -1.52% | |
| Form 6-K Evogene Ltd. For: Jun 16 | SEC filing · Form 6-K | SEC EDGAR | +0.09% | -3.11% | |
| Form 6-K Evogene Ltd. For: Jun 11 | SEC filing · Form 6-K | SEC EDGAR | -2.40% | +1.85% | |
| Evogene to Present Its Pharma Division Achievements at the BIO International Convention | Press release | PR Newswire | +0.76% | +0.34% | |
| Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica | Press release | PR Newswire | -2.44% | -3.36% | |
| Evogene Reports First Quarter 2026 Financial Results | Press release | PR Newswire | +4.10% | +2.11% | |
| Form 6-K Evogene Ltd. For: May 20 | SEC filing · Form 6-K | SEC EDGAR | +4.10% | +2.11% | |
| Form 6-K Evogene Ltd. For: May 18 | SEC filing · Form 6-K | SEC EDGAR | -0.39% | +2.82% | |
| Evogene to Present at the 24th Schrödinger European User Group Meeting | Press release | PR Newswire | -2.49% | -5.37% | |
| Evogene Schedules First Quarter 2026 Financial Results Release | Press release | PR Newswire | +0.00% | -3.58% | |
| Form EFFECT Evogene Ltd. | SEC filing · Form EFFECT | SEC EDGAR | -1.10% | -3.02% | |
| Form EFFECT Evogene Ltd. | SEC filing · Form EFFECT | SEC EDGAR | +0.01% | -0.05% | |
| Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification | Press release | PR Newswire | +0.01% | -0.05% | |
| Form 6-K Evogene Ltd. For: Apr 02 | SEC filing · Form 6-K | SEC EDGAR | +0.01% | -0.05% | |
| Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock | Press release | PR Newswire | +0.00% | -1.53% | |
| Form 20-F Evogene Ltd. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +5.41% | +1.99% | |
| Form F-3 Evogene Ltd. | SEC filing · Form F-3 | SEC EDGAR | +5.41% | +1.99% | |
| Form POS AM Evogene Ltd. | SEC filing · Form POS | SEC EDGAR | +5.41% | +1.99% | |
| Form S-8 Evogene Ltd. | SEC filing · Form S-8 | SEC EDGAR | +5.41% | +1.99% | |
| Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 | Press release | PR Newswire | +0.00% | -1.53% | |
| Evogene Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | PR Newswire | +0.00% | -5.14% | |
| Form 6-K Evogene Ltd. For: Mar 05 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -5.14% | |
| Evogene Releases CEO Letter to Shareholders | Press release | PR Newswire | -0.71% | +3.20% | |
| Form 6-K Evogene Ltd. For: Feb 25 | SEC filing · Form 6-K | SEC EDGAR | -0.71% | +3.20% | |
| Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release | Press release | PR Newswire | -1.07% | -3.38% | |
| Form D Evogene Ltd. | SEC filing · Form D | SEC EDGAR | +0.00% | -6.60% | |
| Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics | Press release | PR Newswire | +0.00% | +0.62% | |
| Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases | Press release | PR Newswire | -1.46% | -0.97% | |
| Form 6-K Evogene Ltd. For: Feb 11 | SEC filing · Form 6-K | SEC EDGAR | +0.45% | -4.59% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EVGN section they belong to.
Where else EVGN is measured.
EVGN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Allied Healthcare Products, Inc. (AHPI) | 215 | 0.00% | 38% |
| Tactile Systems Technology, Inc. (TCMD) | 215 | +0.25% | 62% |
| AMARANTUS BIOSCIENCE HLDG (AMBS) | 212 | 0.00% | 43% |
| Evoke Pharma, Inc. (EVOK) | 212 | 0.00% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Evogene Ltd. - Ordinary Shares's median reaction calculated?
Every labeled EVGN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 213 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of EVGN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does EVGN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.